Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Libby's H*O*P*E*

Libby's H*O*P*E*

Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education). To learn more go to
Roswell Park Study Suggests Additional Applications for FL118 as Personalized Therapy for Cancer. ... | Roswell Park Cancer Institute -
Identification of six new susceptibility loci for invasive epithelial ovarian cancer..... Nature Genetics : Nature Publishing Group -
6 risk factors for ovarian cancer. ....... | -
The ovarian cancer gamble: ‘I knew I needed a new approach to my treatment.’......... | FOX CT -
New Measure of Benefit Proposed for Ovarian Cancer Patients Who Remain in Remission Over Time. -
Differential Contribution of ROS to Resveratrol-induced Cell Death and Loss of Self-renewal Capacity of Ovarian Cancer Stem Cells. ... - PubMed - NCBI -
Salpingectomy (Fallopian Tube Removal) May Prevent Ovarian Cancer, ACOG Says. ...... -
Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423....... - PubMed - NCBI -
Src as a novel therapeutic target for endometriosis. ..... - PubMed - NCBI -
AKT1 gene amplification as a biomarker of treatment response in ovarian cancer: Mounting evidence of a therapeutic target. ..... -
Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.. ......... - PubMed - NCBI -
The novel 19q12 ISH probe reliably detects both CCNE1 and URI amplification as confirmed by FISH. The combination of 19q12 amplification with Cyclin E1 and URI protein expression may help to select patients more likely to benefit from CDK2 targeted therapies. - Libby's H*O*P*E*
Epithelial ovarian cancer: An overview. ...... - PubMed - NCBI -
Performance Characteristics of a Brief Family History Questionnaire to Screen for Lynch Syndrome in Women with Newly Diagnosed Endometrial Cancer. ..... -
Neurotoxicity in Ovarian Cancer Patients on Gynecologic Oncology Group (GOG) Protocol 218: Characteristics Associated with Toxicity and the Effect of Substitution with Docetaxel: An NRG Oncology/Gynecologic Oncology Group study. ..... -
One Common Genetic Variant and the Bacteria Inside Of Us Help Dictate Inflammation, Antitumor Activity, and Outcome in Cancer Patients. .........| Wistar -
Sox2 Gene Amplification Significantly Impacts Overall Survival in Serous Epithelial Ovarian Cancer. .....-
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol. ...... -
Distinct metabolic responses of an ovarian cancer stem cell line. ....... -
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer. ..... - European Journal of Cancer -
MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. ..... -
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT. ...... - Springer -
Targeting MicroRNA May Benefit Some Ovarian And Breast Cancer Patients. ...... | MD Anderson Cancer Center -
New research shows current approach for detecting BRCA gene mutations misses people at high risk of cancer. .....- Medical News Today -
AstraZeneca's Lynparza (olaparib) Approved in EU for Ovarian Cancer w/BRCA Gene Mutation. .... - December 19, 2014 - -
Contraception May Reduce BRCA-Associated Ovarian Cancers. ...... | Cancer Network -
FDA Approves Myriad's BRACAnalysis CDx for Use with Ovarian Cancer PARP Inhibitor Drug Lynparza (olaparib). ....... | GenomeWeb -
FDA approves Lynparza (olaparib; PARP inhibitor) to treat advanced ovarian cancer with BRCA gene mutation. .......-
Female patients with pseudomyxoma peritonei: a single-institution clinicopathologic study of 35 cases. ... - PubMed - NCBI -
Sertoli-Leydig cell tumor with heterologous element: a case report and a review of the literature. ... - PubMed - NCBI -
Long-Term Survival Metastatic Ovarian Cancer Elderly Patient. ..... - PubMed - NCBI -
Other ways to read this feed:Feed readerFacebook